CCK-58: A novel reagent for studying the regulation of cholecystokinin bioactivity

Peptides

Volumn 17, Issue 8, 1996, Pages 1307-1311

  Raybould, Helen E ^a,b   Reeve Jr , Joseph R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bioactivity; CCK 58; Cholecystokinin; Gastric motility; Pancreas; Pancreatic secretion; Structure function

Indexed keywords

CHOLECYSTOKININ 58; CHOLECYSTOKININ DERIVATIVE; CHOLECYSTOKININ OCTAPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOG; DRUG ACTIVITY; HORMONE RELEASE; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; STOMACH MOTILITY;

AMINO ACIDS; ANIMALS; CHOLECYSTOKININ; DOGS; GASTROINTESTINAL MOTILITY; HUMANS; INDICATORS AND REAGENTS; MALE; PANCREAS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SINCALIDE;

EID: 0030457952     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00200-8     Document Type: Article

References (22)

1. 1. Eberlein, G. A.; Eysselein, V. E.; Hesse, W. H.; Goebell, H.; Schaefer, M.; Reeve, J. R., Jr. Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am. J. Physiol. 253:G477-G482; 1987.
2. 2. Eysselein, V. E.; Eberlein, G. A.; Hesse, W. H.; Singer, M. V.; Goebell, H.; Reeve, J. R., Jr. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J. Biol. Chem. 262:214-217; 1987.
3. 3. Eysselein, V. E.; Eberlein, G. A.; Schaeffer, M.; Grandt, D.; Goebell, H.; Niebel, W.; Rosenquist, G. L.; Meyer, H. E.; Reeve, J. R., Jr. Characterization of the major form of cholecystokinin in human intestine: CCK-58. Am. J. Physiol. 258:G253-G260; 1990.
4. 4. Forster, E. R.; Green, T.; Elliot, M.; Bremner, A.; Dockray, G. J. Gastric emptying in rats: Role of afferent neurons and cholecystokinin. Am. J. Physiol. 258:G552-G556; 1990.
5. 5. Fried, M.; Schwizer, W.; Beglinger, C.; Keller, U.; Jansen, J. B,.; Lamers, C. B. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide. Diabetologia 34:721-726; 1991.
6. 6. Hoffmann, P.; Eberlein, G. A.; Reeve, J. R., Jr.; Bünte, R. H.; Grandt, D.; Goebell, H.; Eysselein, V. E. Comparison of clearance and metabolism of infused cholecystokinin 8 and 58 in dog. Gastroenterology 105:1732-1736; 1993.
7. 7. Huang, S. C.; Zhang, L.; Chiang, H. C.; Wank, S. A.; Maton, P. N.; Gardner, J. D.; Jensen, R. T. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists. Am. J. Physiol. 257:G169-G174; 1989.
8. 8. Liddle, R. A.; Elashoff, J.; Reeve, J. R., Jr. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini. Peptides 7:723-727; 1986.
9. 9. Liddle, R. A.; Gertz, B. J.; Kanayama, S.; Beccaria, L.; Coker, L. D.; Turnbull, T. A.; Morita, E. T. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J. Clin. Invest. 84:1220-1225; 1989.
10. 10. Liddle, R. A.; Gertz, B. J.; Kanayama, S.; Beccaria, L.; Gettys, T. W.; Taylor, I. L.; Rushakoff, R. J.; Williams, V. C.; Coker, L. D. Regulation of pancreatic endocrine function by cholecystokinin: Studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. J. Clin. Endocrinol. Metab. 70:1312-1318; 1990.
11. 11. Louie, D. S.; Liang, J. P.; Owyang, C. Characterization of a new CCK antagonist, L364,718: In vitro and in vivo studies. Am. J. Physiol. 255:G261-G266; 1988.
12. 12. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. T. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193:265-275; 1951.
13. 13. Pendleton, R. G.; Bendesky, R. J.; Schaffer, L.; Nolan, T. E.; Gould, R. J.; Clineschmidt, B. V. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: Studies with L-364,718, a specific cholecystokinin receptor antagonist. J. Pharmacol. Exp. Ther. 241:110-116; 1987.
14. 14. Raybould, H. E.; Roberts, M. E.; Dockray, G. J. Reflex decreases in intragastric pressure in response to cholecystokinin in rats. Am. J. Physiol. 253:G165-G170; 1987.
15. 15. Reeve, J. R., Jr.; Eysselein, V.; Eberlein, G. A.; Chew, P.; Ho, F. J.; Huebner, V. D.; Shively, J. E.; Lee, T. D.; Liddle, R. A. Characterization of canine intestinal cholecystokinin-58 lacking its carboxyl-terminal nonapeptide. Evidence for similar posttranslational processing in brain and gut. J. Biol. Chem. 266:13770-13776; 1991.
16. 16. Reeve, J. R., Jr.; Eysselein, V. E.; Rosenquist, G.; Zeeh, J.; Regner, U.; Ho, F. J.; Chen, P.; Davis, M. T.; Lee, T. D.; Shively, J. E.; Brazer, S. R.; Liddle, R. A. Evidence that CCK-58 has a structure that influences biological activity. Am. J. Physiol. 270:G860-8; 1996.
17. 17. Reeve, J. R., Jr.; Eysselein, V. E.; Walsh, J. H.; Ben-Avram, C. M.; Shively, J. E. New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods. J. Biol. Chem. 261:16392-16397; 1986.
18. 18. Rosenquist, G. L.; Walsh, J. H. Radioimmunoassay of gastrin. In: Glass, G. B. J., ed. Gastrointestinal hormones. New York: Raven Press: 1980:769-795.
19. 19. Turkelson, C. M.; Reeve, J. R., Jr.; Solomon, T. E. Low immunoreactivity of canine cholecystokinin-58. Gastroenterology 99:646-651; 1990.
20. 20. Turkelson, C. M.; Solomon, T. E.; Bussjaeger, L.; Turkelson, J.; Ronk, M.; Shively, J. E.; Ho, F. J.; Reeve, J. R., Jr. Chemical characterization of rat cholecystokinin-58. Peptides 9:1255-1260; 1988.
21. 21. Walsh, J. H. Gastrointestinal hormones. In: Johnson, L. R.; Christensen, J.; Jacobson, M. J.; Walsh, J. H., eds. Physiology of the gastrointestinal tract. New York: Raven Press: 1987:181-253.
22. 22. Wank, S. A. Cholecystokinin receptors. Am. J. Physiol. 269:G628-G648; 1995.